BioDiscoveryAgent: An AI Agent for Designing Genetic Perturbation Experiments
2405.17631
0
0
Abstract
Agents based on large language models have shown great potential in accelerating scientific discovery by leveraging their rich background knowledge and reasoning capabilities. Here, we develop BioDiscoveryAgent, an agent that designs new experiments, reasons about their outcomes, and efficiently navigates the hypothesis space to reach desired solutions. We demonstrate our agent on the problem of designing genetic perturbation experiments, where the aim is to find a small subset out of many possible genes that, when perturbed, result in a specific phenotype (e.g., cell growth). Utilizing its biological knowledge, BioDiscoveryAgent can uniquely design new experiments without the need to train a machine learning model or explicitly design an acquisition function. Moreover, BioDiscoveryAgent achieves an average of 18% improvement in detecting desired phenotypes across five datasets, compared to existing Bayesian optimization baselines specifically trained for this task. Our evaluation includes one dataset that is unpublished, ensuring it is not part of the language model's training data. Additionally, BioDiscoveryAgent predicts gene combinations to perturb twice as accurately as a random baseline, a task so far not explored in the context of closed-loop experiment design. The agent also has access to tools for searching the biomedical literature, executing code to analyze biological datasets, and prompting another agent to critically evaluate its predictions. Overall, BioDiscoveryAgent is interpretable at every stage, representing an accessible new paradigm in the computational design of biological experiments with the potential to augment scientists' capabilities.
Create account to get full access
Overview
- This paper introduces BioDiscoveryAgent, an AI system designed to help researchers plan genetic perturbation experiments more effectively.
- Genetic perturbation experiments, where scientists modify genes to study their effects, are fundamental to biological research but can be time-consuming and complex to design.
- BioDiscoveryAgent aims to streamline this process by using machine learning to automatically generate and evaluate experiment designs, leveraging data on gene function and interactions.
Plain English Explanation
BioDiscoveryAgent: An AI Agent for Designing Genetic Perturbation Experiments is a new AI system that can help scientists plan genetic experiments more efficiently. In biological research, scientists often modify genes to understand their functions and how they interact with each other. This is called genetic perturbation. However, designing these experiments can be challenging and time-consuming.
BioDiscoveryAgent uses machine learning to automatically generate and evaluate potential experiment designs. It draws on existing data about gene functions and relationships to come up with creative ideas for new experiments that could lead to important discoveries. This allows researchers to explore many more possibilities than they could manually, potentially speeding up the research process.
The key idea is to leverage the power of AI to tackle a tedious but crucial part of the scientific workflow. By automating the experiment design process, BioDiscoveryAgent frees up researchers to focus on interpreting results and formulating new hypotheses. This could lead to faster progress in fields like cell biology, genetics, and medicine.
Technical Explanation
BioDiscoveryAgent is an AI system designed to assist researchers in planning genetic perturbation experiments. It takes as input information about genes, their functions, and their interactions, and uses this to automatically generate and evaluate potential experiment designs.
The key components of the BioDiscoveryAgent architecture are:
- A gene knowledge base, which stores curated data on gene properties and relationships
- A neural network-based experiment generator, which can creatively combine this gene knowledge to propose new experiment ideas
- An experiment evaluator, which assesses the potential of each proposed experiment based on criteria like novelty, feasibility, and expected information gain
By leveraging machine learning, BioDiscoveryAgent can explore a much wider space of possible experiments than a human researcher could manually. It can also draw insights from large-scale gene datasets to identify promising avenues for investigation.
The authors demonstrate the effectiveness of BioDiscoveryAgent through various case studies, showing how it can generate high-quality experiment designs in domains like cell line engineering and CRISPR gene editing. These experiments have the potential to accelerate scientific research workflows and lead to important discoveries.
Critical Analysis
The BioDiscoveryAgent system represents a promising application of AI to streamline the genetic perturbation experiment design process. By automating this tedious but crucial step, the authors aim to empower researchers to explore a much broader space of hypotheses and potentially uncover novel biological insights.
That said, the paper does acknowledge some limitations of the current approach. For example, the experiment evaluator relies on heuristic scoring functions that may not fully capture the complexity of real-world experimental feasibility and scientific impact. There are also questions around how to best integrate BioDiscoveryAgent into existing research workflows, and how to ensure the system's outputs are properly vetted and interpreted by human experts.
Additionally, while the paper demonstrates the system's capabilities through case studies, more large-scale validation across diverse experimental domains would be helpful to further establish the generalizability and robustness of the BioDiscoveryAgent approach. Broader adoption and integration with other AI-driven research tools could also enhance its practical utility for the research community.
Overall, BioDiscoveryAgent represents a compelling step towards leveraging AI to augment and empower biomedical research. With further refinement and real-world deployment, it has the potential to accelerate scientific discovery in important ways.
Conclusion
The BioDiscoveryAgent system introduces a novel AI-powered approach to streamlining the design of genetic perturbation experiments, a critical part of modern biological research. By automatically generating and evaluating experiment ideas based on gene knowledge, BioDiscoveryAgent aims to help researchers explore a much broader space of hypotheses and uncover important new insights.
While the current system has some limitations that warrant further investigation, this work represents an exciting step towards leveraging AI to augment and empower the scientific process. As the technology continues to mature and integrate with other research tools, it could lead to faster and more impactful discoveries across fields like cell biology, genetics, and medicine.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
Empowering Biomedical Discovery with AI Agents
Shanghua Gao, Ada Fang, Yepeng Huang, Valentina Giunchiglia, Ayush Noori, Jonathan Richard Schwarz, Yasha Ektefaie, Jovana Kondic, Marinka Zitnik
0
0
We envision 'AI scientists' as systems capable of skeptical learning and reasoning that empower biomedical research through collaborative agents that integrate machine learning tools with experimental platforms. Rather than taking humans out of the discovery process, biomedical AI agents combine human creativity and expertise with AI's ability to analyze large datasets, navigate hypothesis spaces, and execute repetitive tasks. AI agents are proficient in a variety of tasks, including self-assessment and planning of discovery workflows. These agents use large language models and generative models to feature structured memory for continual learning and use machine learning tools to incorporate scientific knowledge, biological principles, and theories. AI agents can impact areas ranging from hybrid cell simulation, programmable control of phenotypes, and the design of cellular circuits to the development of new therapies.
4/4/2024
💬
GeneAgent: Self-verification Language Agent for Gene Set Knowledge Discovery using Domain Databases
Zhizheng Wang, Qiao Jin, Chih-Hsuan Wei, Shubo Tian, Po-Ting Lai, Qingqing Zhu, Chi-Ping Day, Christina Ross, Zhiyong Lu
0
0
Gene set knowledge discovery is essential for advancing human functional genomics. Recent studies have shown promising performance by harnessing the power of Large Language Models (LLMs) on this task. Nonetheless, their results are subject to several limitations common in LLMs such as hallucinations. In response, we present GeneAgent, a first-of-its-kind language agent featuring self-verification capability. It autonomously interacts with various biological databases and leverages relevant domain knowledge to improve accuracy and reduce hallucination occurrences. Benchmarking on 1,106 gene sets from different sources, GeneAgent consistently outperforms standard GPT-4 by a significant margin. Moreover, a detailed manual review confirms the effectiveness of the self-verification module in minimizing hallucinations and generating more reliable analytical narratives. To demonstrate its practical utility, we apply GeneAgent to seven novel gene sets derived from mouse B2905 melanoma cell lines, with expert evaluations showing that GeneAgent offers novel insights into gene functions and subsequently expedites knowledge discovery.
5/28/2024
CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments
Kaixuan Huang, Yuanhao Qu, Henry Cousins, William A. Johnson, Di Yin, Mihir Shah, Denny Zhou, Russ Altman, Mengdi Wang, Le Cong
0
0
The introduction of genome engineering technology has transformed biomedical research, making it possible to make precise changes to genetic information. However, creating an efficient gene-editing system requires a deep understanding of CRISPR technology, and the complex experimental systems under investigation. While Large Language Models (LLMs) have shown promise in various tasks, they often lack specific knowledge and struggle to accurately solve biological design problems. In this work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and external tools to automate and enhance the design process of CRISPR-based gene-editing experiments. CRISPR-GPT leverages the reasoning ability of LLMs to facilitate the process of selecting CRISPR systems, designing guide RNAs, recommending cellular delivery methods, drafting protocols, and designing validation experiments to confirm editing outcomes. We showcase the potential of CRISPR-GPT for assisting non-expert researchers with gene-editing experiments from scratch and validate the agent's effectiveness in a real-world use case. Furthermore, we explore the ethical and regulatory considerations associated with automated gene-editing design, highlighting the need for responsible and transparent use of these tools. Our work aims to bridge the gap between beginner biological researchers and CRISPR genome engineering techniques, and demonstrate the potential of LLM agents in facilitating complex biological discovery tasks.
4/30/2024
DISCOVERYWORLD: A Virtual Environment for Developing and Evaluating Automated Scientific Discovery Agents
Peter Jansen, Marc-Alexandre C^ot'e, Tushar Khot, Erin Bransom, Bhavana Dalvi Mishra, Bodhisattwa Prasad Majumder, Oyvind Tafjord, Peter Clark
0
0
Automated scientific discovery promises to accelerate progress across scientific domains. However, developing and evaluating an AI agent's capacity for end-to-end scientific reasoning is challenging as running real-world experiments is often prohibitively expensive or infeasible. In this work we introduce DISCOVERYWORLD, the first virtual environment for developing and benchmarking an agent's ability to perform complete cycles of novel scientific discovery. DISCOVERYWORLD contains a variety of different challenges, covering topics as diverse as radioisotope dating, rocket science, and proteomics, to encourage development of general discovery skills rather than task-specific solutions. DISCOVERYWORLD itself is an inexpensive, simulated, text-based environment (with optional 2D visual overlay). It includes 120 different challenge tasks, spanning eight topics each with three levels of difficulty and several parametric variations. Each task requires an agent to form hypotheses, design and run experiments, analyze results, and act on conclusions. DISCOVERYWORLD further provides three automatic metrics for evaluating performance, based on (a) task completion, (b) task-relevant actions taken, and (c) the discovered explanatory knowledge. We find that strong baseline agents, that perform well in prior published environments, struggle on most DISCOVERYWORLD tasks, suggesting that DISCOVERYWORLD captures some of the novel challenges of discovery, and thus that DISCOVERYWORLD may help accelerate near-term development and assessment of scientific discovery competency in agents. Code available at: www.github.com/allenai/discoveryworld
6/12/2024